Skip to content

The effect of vitamin D supplementation on male infertility

The effect of vitamin D supplementation on spermatogram, seminal and serum levels of oxidative stress indices in idiopathic oligoasthenospermia infertile men: triple blind clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151128025274N4
Enrollment
86
Registered
2018-03-28
Start date
2018-04-29
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Infertility. Male infertility

Interventions

Intervention 1: Intervention group: Patients in the intervention group will receive vitamin D supplementation (in tablet form) at a dose of 4,000 units per day for 12 weeks. Vitamin D supplementation

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 49 Years

Inclusion criteria

Inclusion criteria: Willing to participate in the study and filling out the informed consent form They should be infertile (no conception after 12 months intercourse without any contraception) Age 20-49 y.o. Idiopathic oligoasthenozoospermia according to WHO criteria Vitamin D levels = 30 ng, ml Normal hormonal profile

Exclusion criteria

Exclusion criteria: Any known causes of infertility (such as infection in genitourinary (GU) tract, anatomical abnormality in GU tract, immunological and etc.) Any chronic disease and any surgery in GU tract Any antioxidant supplements consumption, drug treatment or alcohol consumption during last 3 months Candidate for ICSI (sperm injection inside the cytoplasm) Contact with pesticides, heavy metals and solvents Severe physical activity and body mass index (BMI) higher than 30 and less than 18.5 kg,m2

Design outcomes

Primary

MeasureTime frame
Total sperm count. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: Spermatogram.;Sperm Motility. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: Spermatogram.;Serum and seminal Total Antioxidant Capacity. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: ELISA.;Serum and seminal Malondialdehyde. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: ELISA.;Seminal 8-hydroxy Deoxy guanosine. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: ELISA.;Serum 25 hydroxyvitamin D. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: ELISA.;Serum and seminal calcium. Timepoint: Before the start of the intervention and 12 weeks after the intervention. Method of measurement: Calorimetry.;Serum phosphate. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: Calorimetry.;Spermatozoa intracellular calcium. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: ELISA.;Serum Parathormon. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: ELISA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Maghsoumi-Norouzabad

Ahvaz University of Medical Sciences

l.maghsumi55@gmail.com+98 61 3373 8330

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 22, 2026